Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine Physicians

In France, venous thromboembolic (VTE) disease is usually managed by vascular medicine physicians (VMP). The national OPTIMEV study, conducted more than 12 years ago among VMP practicing in hospital and in the community described the management of VTE in routine clinical practice. Since then a large number of practice changing studies have been published. This includes trials that have validated the use of direct oral anticoagulants (DOAC), the new standard of care of VTE, as per new national and international guidelines. Management of VTE in 2019 appears to be significantly different from the one that prevailed more than 10 years ago when the last national survey was conducted. It is therefore important to have an update on the routine clinical practice management of VTE by VMP. In this perspective the investigators aim to conduct a national survey among VMP practicing in France

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Survey Anticoagulant Cardiovascular Diseases Deep Vein Thrombosis Embolism Embolism and Thrombosis Lung Diseases Pulmonary Embolism Respiratory Tract Diseases Thromboembolism Thrombosis Vascular Diseases Venous Thromboembolism Venous Thrombosis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Amiens

Amiens, 80480, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

vascular medicine physicians who are active members of the SFMV (French Society of Vascular Medicine)
vascular medicine physicians registered as willing to do medical research

Exclusion criteria

vascular medicine physicians who refuse to provide consent
vascular medicine physicians who are retired
non-practicing vascular medicine physicians

Treatment and study plan

Primary outcomes

Inter-practician variability of clinical care of venous thromboembolic in routine clinical practice

Time frame: up to 3 months after inclusion

The variation in venous thromboembolic management in routine clinical practice is assessed by analysing the management of the 5 consecutive acute venous thromboembolic patients reported by each participating physician

Secondary outcomes

Inter-practician variability of clinical care of venous thromboembolic according to patient age

Time frame: up to 6 months after inclusion

patient characteristics are : cancer, extreme body weight, severe renal impairment, elderly or pregnant patients, high bleeding risk
Inter-practician variability of clinical care of venous thromboembolic according to patient body weight

Time frame: up to 6 months after inclusion

patient characteristics are : cancer, extreme body weight, severe renal impairment, elderly or pregnant patients, high bleeding risk
Inter-practician variability of clinical care of venous thromboembolic according to patient bleeding risk

Time frame: up to 6 months after inclusion

patient characteristics are : cancer, extreme body weight, severe renal impairment, elderly or pregnant patients, high bleeding risk

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire, Amiens

Other

Registry information

Acronym: Observ-MTEV

Important dates

Study start: 2019
Primary completion: 2023
Study completion: 2023
First posted: Feb 17, 2020
Registry last updated: Jul 12, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed